Article details
Fakeeh Care, a leading Saudi healthcare provider, announced plans to finalize the acquisition of Dr. Mohammed bin Rashid Alfagih Partners Co. next month after completing due diligence and securing 80% of the SAR 2.2 billion financing from Saudi National Bank (SNB) and Saudi Awwal Bank (SAB). The acquisition aims to expand Fakeeh Care’s hospital capacity by adding 350 beds in Riyadh, increasing its total to 1,190 beds. The remaining funds will support capital investments in medical equipment, staff recruitment, and technology upgrades. The company also plans to open three major healthcare centers in Jeddah and Makkah this year and expand into Jazan and Dubai.
This acquisition strengthens Fakeeh Care’s position in Saudi Arabia’s growing healthcare sector, which is a strategic focus under Vision 2030. The move could boost investor confidence in the company’s growth trajectory, potentially impacting its stock performance. The healthcare sector in Saudi Arabia is expected to benefit from increased government spending and private sector investments, making this acquisition a significant development for market participants.
For Gulf investors, the expansion into new regions and the transformation of health colleges into a university signal long-term growth potential. Traders should monitor Fakeeh Care’s stock for volatility around the acquisition’s completion and track the company’s progress in executing its expansion plans. The integration of Alfagih’s operations and the success of new centers will be critical indicators for future performance.
